The Response To Ajmaline Provocation in Healthy Subjects
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02933437
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- St George's, University of London
- Registry
-
NCT02933437 -
2016-004277-41
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT02933437. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-10-22 (actual); primary completion 2019-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Response To Ajmaline Provocation in Healthy Subjects
- Condition
- Brugada Syndrome
- Condition
- Sudden Death
- Intervention (Drug)
- Ajmaline
- Lead sponsor
- St George's, University of London
Record details
- Record id
cardio:ct-nct02933437- Content hash
a55d8a9f79bc74d6a8d87809a92c4bdaaafccac94d72587286604d46567028a2